US nonclinical test design guidance:
This article was originally published in Clinica
Executive Summary
The US FDA has issued a draft guidance on how to design nonclinical tests to determine the potential risk of radiation-induced injuries months or even years after a patient undergoes radiation therapy for cancer or other conditions. The guidance is not intended for diagnostic radiopharmaceuticals or for radiobiologicals, a June 20 Federal Register notice pointed out. Comments are due by September 19.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.